Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis.
Authors not in graph record · peer-reviewed
Study design and participants
- Design
- meta-analysis of RCTs
- Sample size
- 6
- Population
- adults with episodic migraine, prophylaxis
- Intervention and protocol
- commonly 300 mg/day in the trials
Results
- CoQ10 → migraine frequency: positive; effect size not reported.
Limitations, bias, and funding
Risk of bias: moderate
Funding: not reported
- Recorded risk of bias: moderate.